http://dspace.bsu.edu.ru/handle/123456789/46656| Title: | A new EPOR/CD131 heteroreceptor agonist EP-11-1: a neuroprotective effect in experimental traumatic brain injury |
| Authors: | Antsiferov, O. V. Cherevatenko, R. F. Korokin, M. V. Gureev, V. V. Kolesnik, I. M. |
| Keywords: | medicine pharmacology traumatic brain injury secondary failure trimetazidine erythropoietin derivatives |
| Issue Date: | 2021 |
| Citation: | A new EPOR/CD131 heteroreceptor agonist EP-11-1: a neuroprotective effect in experimental traumatic brain injury / O.V. Antsiferov [et al.] // Research Results in Pharmacology. - 2021. - Vol.7, №4.-P. 1-9. - Doi: 10.3897/rrpharmacology.7.75301. |
| Abstract: | EP-11-1 (UEHLERALNSS) is a short-chain erythropoietin derivative without have erythropoietic activity. It was created by modifying a peptide mimicking the spatial structure of the erythropoietin a-helix B pHBSP. One of the promising directions of its administration is the correction of morphofunctional disorders that occur in traumatic brain injury (TBI) |
| URI: | http://dspace.bsu.edu.ru/handle/123456789/46656 |
| Appears in Collections: | Vol. 7, № 4 |
| File | Description | Size | Format | |
|---|---|---|---|---|
| Antsiferov_A new EPOR.pdf | 477.11 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.